'We Know We Will Emerge Stronger In The U.S.,' Says Ranbaxy CEO Atul Sobti: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Indian generic firm's new chief executive talks about adapting to majority ownership by Daiichi Sankyo and about being under the FDA magnifying glass.